Our Recommendations
New Publications
- NTDs Part 1: Buruli Ulcer, Chagas, Leishmaniasis (2024)
- Consulta técnica regional OPS/MSF sobre Organización y estructura de la atención médica del enfermo o infectado por Trypanosoma cruzi (enfermedad de Chagas) (2005)
- Chagas Disease Treatment Market Huge Growth in Future Scope 2023-2030 (2023)
- Reimagining the fight against Chagas disease (2020)
- An Update on the Knowledge of Parasite–Vector Interactions of Chagas Disease (2022)
Filter
45
Featured
Recommendations
2
New Publications
2
Language
Document type
Studies & Reports
15
Guidelines
12
Resource Platforms
6
Fact sheets
5
Strategic & Response Plan
4
Manuals
2
No document type
1
Countries / Regions
Latin America and the Carribbean
22
Global
16
Colombia
4
North America
4
Mexico
2
USA
2
Bolivia
2
China
1
Peru
1
Venezuela
1
Germany
1
Western Pacific Region
1
Western and Central Europe
1
Uruguay
1
Spain
1
Argentina
1
Brazil
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Toolboxes
Chagas
22
Overview, Studies & Reports
11
Clinical Aspects & Diagnostics
9
NTDs
5
Pharmacy
2
Public Health
2
Zoonoses
2
Strategies & Roadmaps
2
Information & Education Material (IEC)
2
Studies & Reports
2
NTDs General
2
Vector control
2
Clinical Guidelines
1
Sustainable Development Goals
1
Dengue & Chikungunya
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Statistics & Facts
1
Statistics & Facts
1
Clinical Aspects & Diagnostics
1
Co-Morbidities (except TB)
1
Zika
1
MEDBOX Issue Brief no.35: The first issue brief on the NTD Toolbox contains general strategies, roadmaps, key treatment guidelines, reports, and training material on Buruli ulcer, Chagas, and Leishmaniasis.
Coherent Market Insights has announced the addition of Chagas Disease Treatment Market 2023 Forecast Analysis by Types, Applications, Size, Share, Key Players, and Regions. a new research report to its market research archive. The Chagas Disease Treatment Market has been thoroughly researched and an...
El presente decálogo expone de manera concisa los aspectos esenciales de la enfermedad y recoge 10 puntos básicos, esquemáticos y orientados a la práctica para la atención pediátrica de la enfermedad de Chagas.
The annual celebration of International Chagas Day on the 14th of April highlights the impact of this disease on the global health scenario.
Education and information about Chagas Disease epidemiology and risk factors.
La enfermedad de Chagas, también conocida como tripanosomiasis americana, es causada por el parásito Trypanosoma cruzi. La forma más común de contraer la infección es a través del contacto con las heces de un insecto triatominio (conocido con los nombres de chinche besucona, benchuca, vinchuca...
Education and information about Chagas Disease, Triatomine bugs, Kissing Bugs, fact sheets, information for special groups, prevention and control, epidemiology, diagnosis and treatment for Health Professionals.
Providing information, education and communication for key people involved in Chagas disease control
The Information, education and communication (IEC) activities, with the development of contextualized activities for various actors and scenarios about preventative measures and surveillance tools, are essential to increase awareness, reduce biomedical and psychosocial barriers to accessing diagnosi...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is
found mainly in endemic areas of 21 Latin American countries. Chagas disease was once entirely
...
Chagas disease (CD) is endemic in the Americas, being present in 21 countries, where it affects about 6 million
people.(1) With such relevant numbers of people affected and disability adjusted life years lost, CD is a poverty-related
and poverty-promoting disease.
Although data describe a relevan...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
DOI: 10.5772/intechopen.102891Little progress has been made since the 1960s and 19. 70s to widen the therapeutic arsenal against Trypanosoma cruzi, the causative pathogen of Chagas disease, which remains a frustrating and perplexing infectious disease. This chapter focuses on the strategic and opera...
This review focusses on the interactions between the etiologic agent of Chagas disease, Trypanosoma cruzi, and its triatomine vector. The flagellate mainly colonizes the intestinal tract of the insect. The effect of triatomines on trypanosomes is indicated by susceptibility and refractoriness phenom...
La transmisión de T. cruzi de un donante con la enfermedad de Chagas a un receptor de trasplante es poco frecuente y es resultado de la aplicación de un tratamiento quirúrgido. En este documento se proponen diez pautas para manejar y prevenir la transmisión de la enfermedad de Chagas por traspla...
Enfermedad de Chagas e inmunosupresión. Decálogo para la prevención, el diagnóstico y el tratamiento
Según las estimaciones, en las Américas hay entre 6 y 8 millones de personas con infección por T. cruzi, con aproximadamente 30 000 casos nuevos por año por transmisión vectorial, y 8000 casos nuevos anuales por transmisión congénita. Es decir, cerca de 65 millones de personas viven en la Reg...
